Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Harvard Business School
Merck
Cipla
Johnson and Johnson
Express Scripts
McKesson
US Department of Justice

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017111

« Back to Dashboard

NDA 017111 describes MOBAN, which is a drug marketed by Endo Pharms and is included in two NDAs. Additional details are available on the MOBAN profile page.

The generic ingredient in MOBAN is molindone hydrochloride. There are four drug master file entries for this compound. Additional details are available on the molindone hydrochloride profile page.
Summary for 017111
Tradename:MOBAN
Applicant:Endo Pharms
Ingredient:molindone hydrochloride
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017111

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 017111

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-006 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-007 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-008 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Farmers Insurance
Healthtrust
Colorcon
Baxter
Accenture
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.